Trial Details

RECRUITING
Basic Information
Clinical ID c187
Identifier NCT07000383
Trial Title Evaluation of the Efficacy and Safety of Gelsectan in the Treatment of Diarrhea-predominant Irritable Bowel Syndrome
Trial URL Visit Original Page
Study Information
Study Results

NO

Conditions Diarrhea-predominant Irritable Bowel Syndrome|Irritable Bowel Syndrome of Diarrhea Type (IBS-D)
Interventions DEVICE: Gelsectan|DRUG: Antispasmodic Agent
Participant Information
Sponsor University Medical Center Ho Chi Minh City (UMC)
City Ho Chi Minh City
Country/Region Vietnam
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase NA
Time Information
Start Date 2025-06-15
Primary Completion Date 2026-01-31
Completion Date 2026-03-31